Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,170.00
+20.00 (0.33%)
Last updated: Jul 11, 2025

Kyung Dong Pharmaceutical Revenue

Kyung Dong Pharmaceutical had revenue of 45.81B KRW in the quarter ending March 31, 2025, with 1.61% growth. This brings the company's revenue in the last twelve months to 194.66B, up 14.35% year-over-year. In the year 2024, Kyung Dong Pharmaceutical had annual revenue of 193.94B with 19.22% growth.

Revenue (ttm)
194.66B
Revenue Growth
+14.35%
P/S Ratio
0.85
Revenue / Employee
556.18M
Employees
350
Market Cap
165.69B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 193.94B 31.26B 19.22%
Dec 31, 2023 162.67B -20.04B -10.97%
Dec 31, 2022 182.72B 5.11B 2.88%
Dec 31, 2021 177.61B 3.78B 2.18%
Dec 31, 2020 173.83B -2.67B -1.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Celltrion 3,662.23B
Kia Corporation 109.25T
Revenue Rankings